Victory Capital Management
AUTL

Victory Capital Management’s Autolus Therapeutics AUTL Stock Holding History

Victory Capital Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-132,580
Closed -$461K – 2486
2024
Q2 		$461K Sell
132,580
-2,580
-2% -$11.1K ﹤0.01% 2003
2024
Q1 		$862K Buy
135,160
+15,930
+13% +$99.4K ﹤0.01% 1807
2023
Q4 		$768K Buy
+119,230
New +$455K ﹤0.01% 1834
2021
Q2 		– Sell
-6,014
Closed -$34K – 2748
2021
Q1 		$34K Sell
6,014
-73,106
-92% -$541K ﹤0.01% 2693
2020
Q4 		$707K Sell
79,120
-13,020
-14% -$139K ﹤0.01% 1914
2020
Q3 		$1.07M Sell
92,140
-2,810
-3% -$40.7K ﹤0.01% 1666
2020
Q2 		$1.52M Sell
94,950
-575,894
-86% -$6.39M ﹤0.01% 1535
2020
Q1 		$4.02M Buy
670,844
+423,657
+171% +$3.92M ﹤0.01% 1334
2019
Q4 		$3.26M Sell
247,187
-46,973
-16% -$615K ﹤0.01% 1337
2019
Q3 		$3.65M Buy
294,160
+198,600
+208% +$2.62M ﹤0.01% 1261
2019
Q2 		$1.54M Buy
95,560
+53,330
+126% +$1.19M ﹤0.01% 1206
2019
Q1 		$1.33M Sell
42,230
-470
-1% -$13.4K ﹤0.01% 1184
2018
Q4 		$1.4M Sell
42,700
-35,980
-46% -$1.18M ﹤0.01% 1125
2018
Q3 		$2.37M Sell
78,680
-40,340
-34% -$1.09M ﹤0.01% 1070
2018
Q2 		$3.19M Buy
+119,020
New +$3.15M 0.01% 971

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Victory Capital Management's AUTL Position: Q3 2024 in Review

Victory Capital Management sold out of Autolus Therapeutics (AUTL) in Q3 2024, closing a stake of 132,580 shares — an estimated $461K sold.

Victory Capital Management first reported a position in AUTL in Q2 2018 and held it in 15 quarters. The position peaked at $4.02M in Q1 2020. 101 funds tracked by Wall St. Rank hold AUTL as of Q3 2024.

  • Victory Capital Management reported no remaining Autolus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Victory Capital Management sold 132,580 Autolus Therapeutics shares in Q3 2024, an estimated $461K.
  • Victory Capital Management first reported a position in Autolus Therapeutics in Q2 2018 and held it in 15 quarters.
  • Victory Capital Management's Autolus Therapeutics position peaked at $4.02M in Q1 2020.
  • 101 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2024.

Based on Victory Capital Management's 13F filing for Q3 2024, filed 5 Nov 2024.